North America Microbiome Therapeutics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Microbiome Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Microbiome Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Microbiome Therapeutics Market Regional Analysis

6.2 North America Microbiome Therapeutics Market Revenue 2020-2030 (US$ Million)

6.3 North America Microbiome Therapeutics Market Forecast Analysis

7. North America Microbiome Therapeutics Market Analysis – by Type

7.1 Therapeutics and Procedure

7.1.1 Overview
7.1.2 Therapeutics and Procedure: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Microbiome Therapeutics Market Analysis – by Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview
8.1.2 Metabolic Disorder and Obesity: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 C. Difficile Infection

8.2.1 Overview
8.2.2 C. Difficile Infection: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Inflammatory Bowel Disease

8.3.1 Overview
8.3.2 Inflammatory Bowel Disease: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Microbiome Therapeutics Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Homecare

9.3.1 Overview
9.3.2 Homecare: North America Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Microbiome Therapeutics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Microbiome Therapeutics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 North America Microbiome Therapeutics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 US: North America Microbiome Therapeutics Market Breakdown, by Type
10.2.1.1.2 US: North America Microbiome Therapeutics Market Breakdown, by Application
10.2.1.1.3 US: North America Microbiome Therapeutics Market Breakdown, by End User

10.2.1.2 Canada: North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Canada: North America Microbiome Therapeutics Market Breakdown, by Type
10.2.1.2.2 Canada: North America Microbiome Therapeutics Market Breakdown, by Application
10.2.1.2.3 Canada: North America Microbiome Therapeutics Market Breakdown, by End User

10.2.1.3 Mexico : North America Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Mexico : North America Microbiome Therapeutics Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Microbiome Therapeutics Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Microbiome Therapeutics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AOBiome Therapeutics Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Ferring Holdings SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Finch Therapeutics Group Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Pendulum Therapeutics Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Seres Therapeutics Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Microbiome Therapeutics Market

Analysis - by Type (Therapeutics and Procedure), Application (Metabolic Disorder and Obesity, C. Difficile Infection, Inflammatory Bowel Disease, and Others), and End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others)